Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. cystic fibrosis related diabetes published in the journal of cystic fibrosis
Show results for

Refine by
Date

  • This Year
  • Older

Cystic Fibrosis Related Diabetes Published In The Journal Of Cystic Fibrosis Articles & Analysis

15 articles found

ELANE Protein: A Dual-Edged Regulator of Inflammation, Immunity, and Tissue Remodeling

ELANE Protein: A Dual-Edged Regulator of Inflammation, Immunity, and Tissue Remodeling

ELANE, or neutrophil elastase (NE), is a serine protease stored in the azurophilic granules of neutrophils and is encoded by the ELANE gene on chromosome 19. It plays a pivotal role in the host defense system by degrading bacterial proteins, remodeling extracellular matrices, and shaping inflammatory responses. However, the same proteolytic activity that protects against pathogens can, when ...

ByCreative BioMart


Gene Delivery: A New Technology for Cancer Therapy

Gene Delivery: A New Technology for Cancer Therapy

Gene delivery is a therapeutic strategy that’s revolutionizing biotechnology and pharmaceuticals. It involves the delivery of new genetic molecules into target cells to treat diseases. This technology has the implicit to revise the treatment of inherited genetic disorders, cancer and other intractable driseases. Scientists are using a variety of gene delivery strategies to insert new ...

ByCDBioSciences - VLPlant


The Vital and Complex Role of Elastase

The Vital and Complex Role of Elastase

Elastase is a powerful enzyme that plays a critical role in various biological processes, both in physiological and pathological contexts. It belongs to the family of serine proteases, which are enzymes characterized by a unique serine residue in their active site. This enzyme is known for its ability to degrade elastin, a key protein that provides elasticity and resilience to tissues such as ...

ByCreative Enzymes


Biofilm in Acute Surgical Wounds: Advances in Prevention and Treatment

Biofilm in Acute Surgical Wounds: Advances in Prevention and Treatment

What is biofilm? Biofilms are defined as communities of micro-organisms attached to a surface, or one another, and encased within a matrix of extracellular polymeric substance (EPS). The EPS makes up the largest component of the biofilm, and in the biological environment is generally composed of polysaccharides, proteins, glycolipids, blood products, cellular debris, extracellular enzymes, metal ...

BySanara MedTech Inc.


Preclinical Animal Models as A Resource to Explore Rare Diseases

Preclinical Animal Models as A Resource to Explore Rare Diseases

Rare diseases, also known as orphan diseases, are a diverse group of disorders that affect a small percentage of the population. Due to their low prevalence and limited understanding, treating and finding cures for these conditions present significant challenges. However, preclinical animal models have emerged as invaluable resources for advancing research and unraveling the mysteries surrounding ...

ByProtheragen


Comprehensive Insights into Native Porcine Pancreatin: A Versatile Enzyme Preparation

Comprehensive Insights into Native Porcine Pancreatin: A Versatile Enzyme Preparation

Native Porcine Pancreatin, an enzymatic mixture derived from the porcine pancreas, has emerged as a fundamental component in various industries due to its unique enzymatic composition. Comprising amylase, lipase, and protease enzymes, this preparation is celebrated for its multifaceted applications and plays an indispensable role in the pharmaceutical, food, and biotechnology sectors. In this ...

ByCreative Enzymes


Gene Therapy for Cystic Fibrosis

Gene Therapy for Cystic Fibrosis

What is cystic fibrosis? Cystic fibrosis (CF) is a rare genetic disorder that affects the lungs, digestive system, and other organs. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes a protein that regulates chloride ions transport across cell membranes. These mutations cause the CFTR protein to be either absent or not function ...

ByProtheragen


The Development Process of DUBTAC

The Development Process of DUBTAC

The use of Proteolysis Targeting Chimeras (PROTACs) to degrade dysfunctional proteins has shown great potential to target proteins that were previously considered “undruggable”, and several projects have entered clinical evaluation worldwide. Aberrant protein degradation, in fact, is also a pathogenic mechanism in some diseases, such as cystic fibrosis (CF) and some forms of cancer. ...

ByBOC Sciences


Using Ultra-Low Freezers to Maintain the Viability of Cell and Gene Therapy Products

Using Ultra-Low Freezers to Maintain the Viability of Cell and Gene Therapy Products

Many cell and gene therapy solutions have shown considerable promise as a source of possible treatments for a wide range of chronic disorders. However, these sophisticated therapies introduce additional barriers such as the requirements for ultra-low and cryogenic storage, which affect numerous steps of the biomedical solutions’ life cycles, from their development to their administration. ...

ByB Medical Systems


Open-Source AI Platforms: Driving Success through Diversity

Open-Source AI Platforms: Driving Success through Diversity

Digital biomarkers can open a world of possibilities in understanding the nuances of a patient’s behavior and response to treatment. Rather than relying on subjective perceptions of how a patient is responding, digital biomarkers treat patient observation more like an engineering problem. Such precise, sensitive measurements can ultimately influence the future of a patient’s care plan ...

ByAiCure


Mitigating Bias in AI: Holding Innovation to a Higher Standard

Mitigating Bias in AI: Holding Innovation to a Higher Standard

When it comes to building equitable, quality AI, prioritizing diverse data sets needs to be embedded in a developer’s DNA – rather than a “nice to have,” it should be a deliberate framework in which AI is built. Before deploying an algorithm to patients, it should be rigorously evaluated under both common and rare scenarios to ensure it performs as intended and ...

ByAiCure


World Rare Disease Day

World Rare Disease Day

On February 29 (or the last day of February) we celebrate World Rare Disease Day to raise awareness about these diseases, aiming to improve access to diagnosis, treatment and medical care. What are these diseases? Rare diseases are those that occur infrequently in the general population. In Argentina, “rare diseases” are those whose prevalence in the general population is equal to ...

ByBiocientífica S.A.


Benefits of point of care PFT in Rural Health

Benefits of point of care PFT in Rural Health

There’s an island in northern Lake Michigan called Beaver Island. It sits roughly 30 miles offshore of Michigan’s Lower Peninsula, part of an archipelago of other whimsically named islands (including Whiskey, Hog, Garden, and Hat). Roughly 500 hardy souls call Beaver Island home year-round, and the two townships that occupy the land support a small but stable economy that embodies the ...

ByNDD Medical Technologies


Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro

Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro

Intestinal inflammatory diseases are highly complex, which has thus far prevented development of an effective in vitro disease model. With access to a donor-derived cell biobank and the ability to recapitulate region-specific environments of the intestine, Altis Biosystems is working toward the development of an in vitro RepliGut® model to accurately recapitulate the complex intestinal ...

ByAltis Biosystems


Enhancing Human Gut Tissue Models through Gene Editing

Enhancing Human Gut Tissue Models through Gene Editing

The variety of normal and diseased human tissues needed to perform comprehensive screening of drug candidates is a key resource for next-generation preclinical models, but obtaining these tissues is challenging. Gene editing enables Altis Biosystems to offer a diverse array of RepliGut® human gut models tailored for specific research programs. Many Challenges Around Accessing Tissues ...

ByAltis Biosystems

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT